Polypharmacy including falls risk-increasing medications and subsequent falls in community-dwelling middle-aged and older adults

Age and Ageing

Volumn 44, Issue 1, 2015, Pages 90-96

  Richardson, Kathryn ^a   Bennett, Kathleen ^a   Kenny, Rose Anne ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Drug therapy; Falls; Older people; Polypharmacy

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; BENZODIAZEPINE DERIVATIVE; DIURETIC AGENT; NEUROLEPTIC AGENT;

ADULT; AGED; AGING; ARTICLE; COHORT ANALYSIS; DEPRESSION; FALL RISK; FALL RISK ASSESSMENT; FALLING; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INCIDENCE; INJURY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MIDDLE AGED; POLYPHARMACY; RISK FACTOR; AGE; INDEPENDENT LIVING; IRELAND; LONGITUDINAL STUDY; PROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; TIME;

ACCIDENTAL FALLS; AGE FACTORS; AGED; AGING; ANTIDEPRESSIVE AGENTS; BENZODIAZEPINES; FEMALE; HUMANS; INDEPENDENT LIVING; IRELAND; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POLYPHARMACY; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 84929625594     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/AGEING/AFU141     Document Type: Article

References (30)

1. O'Loughlin JL, Robitaille Y, Boivin J-F, Suissa S. Incidence of and risk factors for falls and injurious falls among the community-dwelling elderly. Am J Epidemiol 1993; 137: 342-54.
2. Tinetti ME, Speechley M, Ginter SF. Risk factors for falls among elderly persons living in the community. N Engl J Med 1988; 319: 1701-7.
3. Bergland A, Wyller TB. Risk factors for serious fall related injury in elderly women living at home. Inj Prev 2004; 10: 308-13.
4. Kannus P, Sievänen H, Palvanen M, Järvinen T, Parkkari J. Prevention of falls and consequent injuries in elderly people. Lancet 2005; 366: 1885-93.
5. Deandrea S, Lucenteforte E, Bravi F, Foschi R, La Vecchia C, Negri E. Risk factors for falls in community-dwelling older people. Epidemiology 2010; 21: 658-68.
6. Woolcott JC, Richardson KJ, Wiens MO et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 2009; 169: 1952-60.
7. Hartikainen S, Lönnroos E, Louhivuori K. Medication as a risk factor for falls: critical systematic review. J Gerontol A Biol Sci Med Sci 2007; 62: 1172-81.
8. Hilmer SN, Gnjidic D. The effects of polypharmacy in older adults. Clin Pharmacol Ther 2008; 85: 86-8.
9. Lawlor DA. Association between falls in elderly women and chronic diseases and drug use: cross sectional study. BMJ 2003; 327: 712-7.
10. Ziere G, Dieleman JP, Hofman A, Pols HA, Van Der Cammen TJM, Stricker BHC. Polypharmacy and falls in the middle age and elderly population. Br J Clin Pharmacol 2006; 61: 218-23.
11. Barrett A, Savva G, Timonen V, Kenny RA, eds. Fifty Plus in Ireland 2011. First Results From The Irish Longitudinal Study on Ageing. Dublin: TILDA, 2011.
12. Whelan BJ, Savva GM. Design and methodology of The Irish Longitudinal Study on Ageing. J Am Geriatr Soc 2013; 61: S265-8.
13. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC Classification and DDD Assignment 2011. Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 2010.
14. Gnjidic D, Hilmer SN, Blyth FM et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol 2012; 65: 989-95.
15. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385-401.
16. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004; 159: 702-6.
17. Neutel CI, Perry S, Maxwell C. Medication use and risk of falls. Pharmacoepidemiol Drug Saf 2002; 11: 97-104.
18. Weiner DK, Hanlon JT, Studenski SA. Effects of central nervous system polypharmacy on falls liability in community-dwelling elderly. Gerontology 1998; 44: 217-21.
19. Nurminen J, Puustinen J, Piirtola M, Vahlberg T, Kivelä S-L. Psychotropic drugs and the risk of fractures in old age: a prospective population-based study. BMC Public Health 2010; 10: 396.
20. Ray WA. Psychotropic drugs and injuries among the elderly: a review. J Clin Psychopharmacol 1992; 12: 386-96.
21. Diem SJ, Blackwell TL, Stone KL et al. Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures. Arch Intern Med 2007; 167: 1240-5.
22. Bhangu J, King-Kallimanis B, Cunningham C, Kenny RA. Prevalence of syncope in older adults with depression: a population based study. Age Ageing 2013; 42(Suppl. 2): ii20-2.
23. Pacher P, Ungvari Z. Selective serotonin-reuptake inhibitor antidepressants increase the risk of falls and hip fractures in elderly people by inhibiting cardiovascular ion channels. Med Hypotheses 2001; 57: 469-71.
24. French DDD, Chirikos TN, Spehar A, Campbell R, Means H, Bulat T. Effect of concomitant use of benzodiazepines and other drugs on the risk of injury in a Veterans population. Drug Saf 2005; 28: 1141-50.
25. Zint K, Haefeli WE, Glynn RJ, Mogun H, Avorn J, Stürmer T. Impact of drug interactions, dosage, and duration of therapy on the risk of hip fracture associated with benzodiazepine use in older adults. Pharmacoepidemiol Drug Saf 2010; 19: 1248-55.
26. Schneeweiss S, Maclure M. Use of comorbidity scores for control of confounding in studies using administrative databases. Int J Epidemiol 2000; 29: 891-8.
27. Richardson K, Kenny RA, Peklar J, Bennett K. Agreement between patient interview data on prescription medication use and pharmacy records in the over 50s varied by therapeutic group and reporting of indicated health condition. J Clin Epidemiol 2013; 66: 1308-16.
28. Ganz DA, Higashi T, Rubenstein LZ. Monitoring falls in cohort studies of community-dwelling older people: effect of the recall interval. J Am Geriatr Soc 2005; 53: 2190-4.
29. Chu LW, Chi I, Chiu AYY. Incidence and predictors of falls in the Chinese elderly. Ann Acad Med Singapore 2005; 34: 60-72.
30. Van der Velde N, Stricker BHC, Pols HAP, van der Cammen TJM. Withdrawal of fall-risk-increasing drugs in older persons: effect on mobility test outcomes. Drugs Aging 2007; 24: 691-9.